Dipeptidyl Peptidase-4 Inhibitor treatment could decrease Klebsiella pneumoniae Pneumonia in patients with type 2 diabetes.

Hsin-Hung Chen,Ching Chu Chen,Chun-Wei Ho,Ming-Chia Hsieh,Sheng-Pang Hsu,Cheng Li Lin,Chia-Hung Kao

Dipeptidyl Peptidase-4 Inhibitor treatment could decrease Klebsiella pneumoniae Pneumonia in patients with type 2 diabetes.

2020

Hsin-Hung Chen
Ching Chu Chen
Chun-Wei Ho
Ming-Chia Hsieh
Sheng-Pang Hsu
Cheng Li Lin
Chia-Hung Kao

To investigate the effect of dipeptidyl peptidase-4 inhibitor (DPP4i) for Klebsiella pneumoniae (KP) pneumonia in patients with diabetes. Patients newly diagnosed with type 2 diabetes from 2009 to ...

Keywords:

Type 2 diabetes
Gastroenterology
Diabetes mellitus
in patient
newly diagnosed
Cohort study
Dipeptidyl peptidase-4 inhibitor
Klebsiella pneumoniae
Medicine
Internal medicine
Physical therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations